Skip to content
Wearables & measurementEvidence review3 min read

Wearables pick up activity and sleep signals in serious mental illness, but evidence is thin

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Utility of Consumer-Grade Wearable Devices for Inferring Physical and Mental Health Outcomes in Severe Mental Illness: Systematic Review. · JMIR mental health · 2025 · Original paper ↗

Key takeaway

A systematic review of 23 papers from 12 distinct studies found some evidence that lower activity, higher heart rates and later, irregular sleep onset were linked to psychiatric diagnoses or poorer symptoms in schizophrenia or bipolar disorder. Devices, measures and statistics varied so much that results are hard to compare.

Study design

Evidence review

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Consumer wearables and smartphones can passively record movement, sleep and heart rate, which could help monitor severe mental illness (SMI) remotely, but their roles are not well understood. The authors reviewed how useful such data are for monitoring or predicting mental or physical health changes in adults with schizophrenia or bipolar disorder.

Who and how

Systematic review (PROSPERO CRD42022382267) of Cochrane Central Register of Controlled Trials, Technology Assessment, AMED, APA PsycINFO, Embase, MEDLINE and IEEE Xplore, searched through May 2024. Studies had to passively collect physiological data such as sleep duration, heart rate, sleep and wake patterns or physical activity for at least 3 days; research-grade actigraphy and physically obtrusive devices were excluded. Results were synthesised narratively because of heterogeneity, grouped as physical activity, sleep and circadian rhythm, and heart rate.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    23 papers reporting on 12 distinct studies were included, mostly using smartphones and centred on relapse prevention. Only 1 study explicitly aimed at physical health outcomes.
  2. 2
    More than 500 participants with SMI contributed data, predominantly from high-income countries. Papers presented physical activity data (n=18), sleep and circadian rhythm data (n=14) and heart rate data (n=6); 8 papers used smartwatches and the rest only smartphones.
  3. 3
    There was some evidence that lower activity, higher heart rates, and later and irregular sleep onset times were associated with psychiatric diagnoses or poorer symptoms.
  4. 4
    Differences in devices, measures, sampling and statistical approaches complicated interpretation.

Limits & uncertainty

  1. 1
    Few studies (12 distinct studies) and over 500 participants in total, mostly from high-income countries, limit how far the findings apply elsewhere.
  2. 2
    Heterogeneity in devices, measures, sampling and statistical methods meant no pooled estimate was possible, and the abstract reports no accuracy figures.
  3. 3
    Only 8 papers used smartwatches and just 6 covered heart rate, so the heart-rate evidence is the thinnest; the associations found do not show that a device can predict relapse in an individual.
  4. 4
    This reading is based on the abstract only.

What to take from it

Passive phone and watch data may someday flag changes in activity or sleep that accompany symptoms, but the evidence is early and inconsistent. These signals are not a diagnosis or a relapse alarm. People living with schizophrenia or bipolar disorder, and their families, should share any concerning changes with their care team.

Reading your own data

The review's signals, daily activity, sleep timing and resting heart rate, are the same ones many wearables record. Compare your own patterns on one device against your own baseline over weeks, and note sleep-onset regularity, but do not treat a change as a diagnosis.

How to read this evidence

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Digital wearable devices, worn on or close to the body, have potential for passively detecting mental and physical health symptoms among people with severe mental illness (SMI); however, the roles of consumer-grade devices are not well understood.

Objective

This study aims to examine the utility of data from consumer-grade, digital, wearable devices (including smartphones or wrist-worn devices) for remotely monitoring or predicting changes in mental or physical health among adults with schizophrenia or bipolar disorder. Studies were included that passively collected physiological data (including sleep duration, heart rate, sleep and wake patterns, or physical activity) for at least 3 days. Research-grade actigraphy methods and physically obtrusive devices were excluded.

Methods

We conducted a systematic review of the following databases: Cochrane Central Register of Controlled Trials, Technology Assessment, AMED (Allied and Complementary Medicine), APA PsycINFO, Embase, MEDLINE(R), and IEEE XPlore. Searches were completed in May 2024. Results were synthesized narratively due to study heterogeneity and divided into the following phenotypes: physical activity, sleep and circadian rhythm, and heart rate.

Results

Overall, 23 studies were included that reported data from 12 distinct studies, mostly using smartphones and centered on relapse prevention. Only 1 study explicitly aimed to address physical health outcomes among people with SMI. In total, data were included from over 500 participants with SMI, predominantly from high-income countries. Most commonly, papers presented physical activity data (n=18), followed by sleep and circadian rhythm data (n=14) and heart rate data (n=6). The use of smartwatches to support data collection were reported by 8 papers; the rest used only smartphones. There was some evidence that lower levels of activity, higher heart rates, and later and irregular sleep onset times were associated with psychiatric diagnoses or poorer symptoms. However, heterogeneity in devices, measures, sampling and statistical approaches complicated interpretation.

Conclusions

Consumer-grade wearables show the ability to passively detect digital markers indicative of psychiatric symptoms or mental health status among people with SMI, but few are currently using these to address physical health inequalities. The digital phenotyping field in psychiatry would benefit from moving toward agreed standards regarding data descriptions and outcome measures and ensuring that valuable temporal data provided by wearables are fully exploited.

Trial registration

PROSPERO CRD42022382267; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=382267.

Sources & attribution

Utility of Consumer-Grade Wearable Devices for Inferring Physical and Mental Health Outcomes in Severe Mental Illness: Systematic Review.

Hassan L, Milton A, Sawyer C, Casson AJ, Torous J, Davies A, Ruiz-Yu B, Firth J.

JMIR mental health · 2025-01-07

DOI: 10.2196/65143 ↗PubMed · 39773905 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Cohort study

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

In-depth explainersRead study →
·Validation study/review

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

In-depth explainersRead study →
·Overview of reviews

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

In-depth explainersRead study →
·Validation study/review

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

In-depth explainersRead study →
Wearables & measurement →